|Bid||47.76 x 1200|
|Ask||48.24 x 3100|
|Day's Range||47.05 - 48.27|
|52 Week Range||34.98 - 48.87|
|Beta (5Y Monthly)||0.82|
|PE Ratio (TTM)||62.54|
|Earnings Date||Jan 31, 2023 - Feb 06, 2023|
|Forward Dividend & Yield||N/A (N/A)|
|1y Target Est||48.95|
In this article we are going to estimate the intrinsic value of Boston Scientific Corporation ( NYSE:BSX ) by...
Boston Scientific Corporation (NYSE: BSX) today announced U.S. Food and Drug Administration (FDA) 510(k) clearance of the LithoVue™ Elite Single-Use Digital Flexible Ureteroscope System, the first ureteroscope system with the ability to monitor intrarenal pressure in real-time during ureteroscopy procedures.
Boston Scientific ( NYSE:BSX ) Full Year 2022 Results Key Financial Results Revenue: US$12.7b (up 6.7% from FY 2021...